Mereo BioPharma MREO Ratios (2017-2026)

NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Mereo BioPharma Quarterly Ratios

Periods 24 quarters
Latest Jun 2026

Mereo BioPharma ratios data for the quarter ended Jun 2026. These financial ratios cover 24 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
61.89%127.30%73.60%
EBT Margin
-19.46%-964.10%-2,923.20%-61,081.82%
EBIT Margin
-9.01%-712.80%-2,099.80%-79,690.91%
EBITDA Margin
-6.71%-694.20%-2,067.40%-78,136.36%
Operating Margin
-9.01%-712.80%-2,099.80%-79,690.91%
Net Margin
-19.46%-910.90%-2,923.20%-61,081.82%
FCF Margin
-86.16%-678.90%-1,530.20%-39,200.00%
Efficiency
Assets AverageAssets Avg.
124.25M61.22M76.03M92.44M82.57M72.36M65.48M58.12M49.76M43.27M37.66M
Equity AverageEquity Avg.
45.64M115.24M101.60M79.50M59.50M47.03M52.19M52.62M46.69M60.74M3.06M-5.78M60.53M57.13M50.39M43.76M37.49M31.35M
Invested CapitalInvested Cap.
1.60M136.51M138.20M103.77M87.95M82.75M50.54M47.47M83.58M-66.99M66.50M60.08M54.18M46.60M40.92M
Asset Utilization RatioAsset Util.
0.160.010.010.000.000.010.010.010.00
Leverage & Solvency
Interest Coverage RatioInterest Cover
-14.26-0.79-12.95-20.19-31.94-38.71-26.55-40.73-62.23-437.46-357.68-364.78-438.30-439.38
Debt Ratio
0.250.170.080.050.060.07
Times Interest Earned
-14.26-0.79-12.95-20.19-31.94-38.71-26.55-40.73-62.23-437.46-357.68-364.78-438.30-439.38
Valuation
Price to SalesP/S
32.4046.29553.87637.650.00M0.00M209.50103.080.00M
Price to BookP/B
1.921.581.551.262.003.423.316.4110.817.049.135.957.967.031.641.551.78
Enterprise Value
-10.00M210.70M62.50M59.89M38.31M25.82M88.74M116.68M180.91M266.57M414.20M466.44M557.13M486.70M295.25M375.03M279.11M26.05M22.57M20.98M
Market Capitalization
59.95M242.69M214.90M187.17M131.02M93.74M88.74M169.81M180.91M323.99M462.90M553.87M637.65M556.50M357.75M431.15M327.81M67.04M52.67M51.10M
Return Ratios
Return on Sales [ROS]ROS
-9.01%-712.80%-269.06%-3,890.90%-3,921.50%-2,099.80%-14,684.69%-12,533.13%-79,690.91%-310,918.18%
Return on Capital Employed [ROCE]ROCE
-53.58%-64.24%-50.13%-68.92%-75.03%-80.02%-90.19%-88.23%-101.57%-106.92%
Return on Invested Capital [ROIC]ROIC
-53.82%-58.54%-467.10%
Return on Assets [ROA]ROA
-43.03%-48.46%-49.02%-52.38%-65.22%-75.68%-71.53%-84.16%-82.54%-74.60%
Return on Equity [ROE]ROE
-56.00%-56.42%-60.66%-1,482.37%-77.97%-86.73%-82.51%-95.71%-95.26%-89.62%

Mereo BioPharma Ratios API

Pull Mereo BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MREO&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY